Antibacterial Layer-by-Layer coatings for medical implants by Escobar, Ane et al.
pharmaceutics
Review
Antibacterial Layer-by-Layer Coatings for Medical Implants
Ane Escobar 1,†, Nicolas Muzzio 2,† and Sergio Enrique Moya 1,*


Citation: Escobar, A.; Muzzio, N.;
Moya, S.E. Antibacterial Layer-by-
Layer Coatings for Medical Implants.
Pharmaceutics 2021, 13, 16.
https://dx.doi.org/10.3390/
pharmaceutics13010016
Received: 20 November 2020
Accepted: 21 December 2020
Published: 24 December 2020
Publisher’s Note: MDPI stays neu-
tral with regard to jurisdictional claims
in published maps and institutional
affiliations.
Copyright: © 2020 by the authors. Li-
censee MDPI, Basel, Switzerland. This
article is an open access article distributed
under the terms and conditions of the
Creative Commons Attribution (CC BY)
license (https://creativecommons.org/
licenses/by/4.0/).
1 Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology
Alliance (BRTA), Paseo de Miramon 182 C, 20014 Donostia-San Sebastian, Spain; ane.escobar@i3bs.uminho.pt
2 Department of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio,
San Antonio, TX 78249, USA; nicolas.muzzio@utsa.edu
* Correspondence: smoya@cicbiomagune.es
† These authors contributed equally to this work.
Abstract: The widespread occurrence of nosocomial infections and the emergence of new bacterial
strands calls for the development of antibacterial coatings with localized antibacterial action that are
capable of facing the challenges posed by increasing bacterial resistance to antibiotics. The Layer-
by-Layer (LbL) technique, based on the alternating assembly of oppositely charged polyelectrolytes,
can be applied for the non-covalent modification of multiple substrates, including medical implants.
Polyelectrolyte multilayers fabricated by the LbL technique have been extensively researched for
the development of antibacterial coatings as they can be loaded with antibiotics, antibacterial pep-
tides, nanoparticles with bactericide action, in addition to being capable of restricting adhesion of
bacteria to surfaces. In this review, the different approaches that apply LbL for antibacterial coatings,
emphasizing those that can be applied for implant modification are presented.
Keywords: bacterial infections; polyelectrolytes; Layer-by-Layer; antibacterial coatings; antiadhesive
surfaces; localized action; medical implants
1. Introduction
A current challenge in the design of biomaterials for tissue engineering and implant
fabrication is the need to inhibit bacterial adhesion/colonization while, at the same time,
facilitating the desired interactions of the implant with cells and proteins [1]. Depending
on the desired application one may aim to promote cell adhesion, migration, proliferation
and differentiation, as in the case of tissue regeneration therapies [2,3], or prevent it, as in
some surgical materials, or in biomaterials to prevent post-operative adhesions [4,5].
The widespread occurrence of bacterial infections and their increasing resistance
to antibiotics has led to the development of a wide variety of antibacterial coatings for
multiple medical settings, especially bone implants [6]. The surface of an implant can
be susceptible to numerous bacterial infections largely due to the formation of a biofilm
on its surface, which triggers a compromised immune response at the implant/tissue
interface [7]. Once a biofilm is formed, it protects adherent bacteria from the host defence
system and bactericidal agents via several mechanisms [8–10]. The biofilm becomes a
source of pathogens and infections, being the cause of so-called nosocomial infections
[11–13]. Because biofilms can develop on almost any material present in a surgical theatre,
preventing their formation is fundamental for patient survival.
Even with the development of therapies based on prophylactic antibiotics, environ-
mental control and the latest improvements in surgical techniques, the incidence of infection
varies between 1–2% in primary arthroplasties and 3.5–5% in revision surgeries. [14,15].
For example, the main risk factors associated with infection in knee arthroplasty are a
previous surgery, advanced age, female gender, rheumatoid arthritis, obesity, diabetes
and immunodeficiency diseases [16]. Post-implantation surgical trauma weakens the local
defence system, raising the risk of infection, which if prolonged requires further surgical in-
terventions to replace the implant [17]. The revision surgery, however, is more challenging
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than the initial surgery because of higher risk of trauma and the need of a longer period for
bone healing [18]. Once the implant is in contact with physiological media, a protein layer
is formed on the surface, facilitating bacterial colonization and in the worst case scenario,
biofilm formation [8,19]. Biofilms act as a protecting layer against the host defence and
bactericidal agents, so it remains highly challenging and critical to avoid infection just after
the implantation surgery [8].
If there is still no need to replace the implant, infection focus has to be removed surgically,
which is followed by a long time treatment with antibiotics [13]. Two-thirds of the infections in
orthopaedic implants are caused by Staphylococcus pathogens. These also are the responsible for
two of the major bone infections: arthritis and osteomyelitis, which suppose the inflammatory
destruction of joints and bones [20]. More specifically Staphylococcus aureus and Staphylococcus
epidermidis account together for two out of three infections in orthopaedics [20].
In the last few decades several approaches have been developed for bringing an-
tibacterial functions to the implants as a more effective alternative to systemic delivery of
antibiotics [21]. The different approaches developed aim to preserve antibacterial activity
through the process of wound healing and capsulate formation [21]. Despite the highest
risk of bacterial infections is during operation when the body is open to the air bacterial in-
fections can take place at any time before capsule closing [22]. By making the surface of the
implants antibacterial undesired effects of delivering large doses of antibiotics systemically
or at the site of implant could be avoided [22]. Many of the strategies developed for bring-
ing antibacterial properties to implants are based on their functionalization with polymer
films, which either act themselves as antibacterial or are used to encapsulate antibiotics,
bring antibacterial functions or decrease bacteria adhesion on the implant [23,24].
In this review a focus on one type of polymeric coating: polyelectrolyte multilayers
(PEMs) fabricated by the Layer-by-Layer (LbL) technique is provided. PEMs are prepared
by the sequential assembly of oppositely charged polyelectrolytes. The technique can be
applied for functionalization of any charged surface requiring simple and inexpensive
procedures. PEM fabrication offers a modular approach to bring antibiotics, bactericide
peptides and nanoparticles, positive charges to disrupt bacteria membranes, and inhibit
bacteria adhesion and proliferation, all in one [25].
2. Nosocomial Infections
The term nosocomial infections refers to infections associated with healthcare and ac-
quired in a hospital [26]. These are infections secondary to the main condition of the patient,
and can have lethal consequences following operations such as bone replacement or open
heart surgery [27–29]. Staphylococcus aureus is an important nosocomial pathogen, able to
cause a variety of conditions. It can often be found as a commensal and a transient, or
persistent part of the resident flora of the skin and anterior nares in a large proportion (20–
50%) of the human population. However, when cutaneous/mucous barriers are breached,
severe and at times life-threatening infections can develop. Nosocomial infections of S. aureus
are particularly frequent in immunocompromised and severely debilitated patients and
prevail in the presence of indwelling medical devices. The treatment of S. aureus infections is
often complex, namely due to the emergence of methicillin-resistant S. aureus (MRSA) strains
and resistance to other classes of antibiotics. Because of its pathogenic potential and the
complexity of its treatment, MRSA has received more attention than its methicillin-sensitive
counterpart (MSSA). MRSAs are resistant to β-lactam antibiotics (e.g., oxacillin, penicillin
and amoxicillin), including third generation cephalosporins, streptomycin, tetracycline and
sulphonamides; and upon exposure to vancomycin and other glycopeptide antibiotics, cer-
tain MRSA strains become less susceptible to these antibiotics. S. aureus possesses several
cell-surface adhesive molecules that facilitate its binding to the bone matrix. Binding in-
volves a family of adhesins that interact with the extracellular matrix (ECM) components,
and these adhesins have been termed microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs). Specific MSCRAMMs are needed for the colonization of
individual tissues and for adhesion to biomaterials and to the ECM proteins deposited on
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the biomaterial surface. MSCRAMMs include fibrinogen-binding proteins, elastin-binding
adhesin and collagen-binding adhesin. A number of these adhesins have already been
thoroughly investigated and identified as critical virulence factors involved in various phases
of infection, including early colonization, invasion, tissue localization and cell internaliza-
tion [30–32]. In recent years, the polysaccharide intercellular adhesin (PIA) has been found
in many S. aureus strains, and is required for biofilm formation and bacterium-bacterium
adhesion [33]. This adhesin is responsible for the production of the extracellular polysaccha-
ride matrix that develops the biofilm. It is known that once a biofilm is formed, the bacteria
within the biofilm are protected from phagocytosis and antibiotics [32].
S. aureus produces virulence factors to facilitate disease progression, and rapidly de-
velops antimicrobial resistance. Virulence factors include the MSCRAMMs as receptors in
the human host, other surface proteins, polysaccharide intercellular adhesion, and capsular
polysaccharides. The cell-surface MSCRAMMs typically are produced during the exponential
growth phase. The role of these various virulence factors is to provide nutrients required for
survival in the host, and microbial cell protection from the host immune system during lesion
formation. The secreted virulence factors, typically produced during the post-exponential
and stationary phases, include a large group of exoenzymes, such as proteases, glycerol ester
hydrolase and nucleases that make nutrients available to the microorganism [32].
3. Coatings for Titanium Implants
The increased use of titanium and its alloys as biomaterials for bone implants in
substitution/repair approaches is a result of their superior biocompatibility and excellent
low corrosion characteristics [34,35]. Since the role of an implant is the replacement of
the bone, it needs to mimic the biological environment and mechanical properties of
the bone. Although currently used commercial titanium implants satisfy the required
mechanical properties with a Young’s modulus within the range of 100 and 120 GPa [36],
the chemical instability and deformations of the protective oxide layer usually results in
poor osteointegration. Surface deformations of the protective layer liberate metal ions
which form Lewis acids and lower the pH in the implant environment [37]. The acidic
environment formed at the implant surface favours bacterial infection and causes an
immunogenic response which can lead to an aseptic loosening of the implant and a second
surgery is needed to replace the infected implant [17,38].
It is well known that the physicochemical properties of the surface/material such as
surface charge, topography, hydrophilicity/hydrophobicity, stiffness, etc., can selectively
promote or prevent the absorption of proteins, and the adhesion of cells and bacteria [39,40].
A large body of work has been dedicated to the development of proper coatings for titanium
implants, which make the surface antibacterial and resistant to bacterial adherence [41].
Due to the diversity of bacterial ecosystems, the coatings should be tailored to tackle specific
bacteria strains. Although post-implementation supply of antibiotics to the patients can
prevent infection, the low drug concentration reaching the target site remains a major
disadvantage [17].
The encapsulation of antibiotics in polymer matrices is an attractive approach for
the fabrication of antibacterial coatings. Polymer coatings can be made out of hydrogels,
Layer-by-Layer (LbL) assemblies, polymer brushes, or porous polymer scaffolds [1,42–52].
A major drawback of the encapsulation of antibiotics in polymer films is the difficulty in
achieving a slow release of antibiotics. In addition, often the coating degrades accompanied
by liberation of the antibiotics all at once, or at a rate faster than required [6,53]. Gentamicin,
cephalothin, amoxicillin, tobramycin, or vancomycin are some of the most used antibiotics
due to their broad antibacterial spectra [54–58].
Non-antibiotic organic antimicrobial agents have also been proposed to avoid the risk
of drug resistance associated with antibiotics [17,59,60]. Inorganic materials such as silver
have also been proposed as an attractive dopant for titanium implants since it exhibits a
broad antibacterial spectrum. However, silver compromises the activity of osteoblasts and
epithelial cells [61,62]. The treatment of the implants with UV irradiation, or by changing
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the surface crystallinity, leads usually to alteration of the physicochemical properties,
and decreases bacterial activity [63]. Interestingly, the use of nitric oxide has also been
proposed as it inhibits the growth of a wide variety of bacteria [64]. Nitric oxide augments
the antimicrobial ability of the immune system, thus it is loaded into xerogels for subsequent
release [65]. Nonetheless, the combination of nitric oxide with titanium implants remains
unproven. Bioactive polymers coatings, such as chitosan are also investigated because they
can reduce bacterial adhesion [66].
4. Layer-by-Layer Technique
By taking advantage of the large tunability offered by the LbL assembly technique and
the large variety of available building blocks, several strategies have been developed based
on LbL to prevent bacterial adhesion and biofilm formation. The fabrication of multilayer
films of polyelectrolytes by means of the LbL technique was first shown by Decher et al. [67].
The LbL technique is based on the alternating deposition of oppositely charged polyelec-
trolytes on top of charged surfaces, this process is shown in Figure 1 [68–70]. The assembly
is driven by attractive electrostatic interactions between polycations and polyanions, and
entropy considerations, related to the release of counterions during polyelectrolyte as-
sembly [71,72]. This technique is a powerful strategy for non-covalent modification of
charged surfaces. LbL is an easy and reliable method for surface engineering and has many
potential applications in diverse areas such as optoelectronics, nanofiltration, catalysis,
and as anti-corrosion coatings [69,73–75]. PEMs have also found a variety of biological and
biomedical applications. These include coatings to either promote or prevent cell adhesion,
drug encapsulation, and directing or maintaining cellular phenotypes [76].
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Figure 1. Layer-by-layer assembly method. Alternatingly, positively and negatively charged
molecules are adsorbed one after the other on a substrate. This process can be repeated n times to a
final film thickness. Adapted with permission from [77], Springer Nature, 2009.
Initially developed for synthetic polyelectrolytes, the LbL technique has been extended
to biopolyelectrolytes and other materials, which are assembled by electrostatic interactions,
by hydrogen bonding, or by ion coordination in a sequential protocol. PEMs can be produced
by combining a diverse array of components. Biopolymers such as proteins and nucleic acids,
lipids, enzymes, and inorganic particles have been introduced in multilayer films expanding
their potential for applications in multiple areas: sensing, filtration, drug delivery or energy,
to name but a few [68,78,79]. In addition, PEMs can be produced by spraying polyelectrolyte
solutions covering large surfaces. Spray based LbL is conceptually as easy as dipping LbL
and can be applied, for example, to cover implants with diverse geometry [80].
PEMs assembled by the LbL technique can be considered a special case of polyca-
tion/polyanion complex formation. Due to the stepwise assembly of polycations and
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polyanions, the film gains a layered structure. However, the layers are not fully strati-
fied, as there is a certain degree of interdigitation among them because of the free space
within a deposited polyelectrolyte layer, which is filled as the number of layers deposited
increases [81]. PEMs are found to be very stable; they cannot be easily removed unless
one of the components loses charge by means of a change in pH, or when a specific ion, or
surfactant, interacts with the polymers weakening the electrostatic interaction between the
polyelectrolytes [82,83]. Only at very high ionic strength can the films be partially erased [84].
Two main types of growth kinetics have been identified in the LbL technique: (i) linear
and (ii) exponential or supralinear. In linear growth the amount of polyelectrolyte assem-
bled per layer is constant while in the exponential or supralinear, the amount of polymer
assembled increases as the number of layers assembled increases, following one of these
two growth laws [85,86]. A supralinear growth mechanism has the advantage that larger
amounts of material can be adsorbed in each assembly step, leading for example to an
increased antibiotic loading and release, as will be described in the following section.
5. LbL for Antibiotic Encapsulation
The LbL technique has been used for the engineering of scaffolds and implants to
assemble growth factors and other molecules that facilitate tissue regeneration or enhance
cell adhesion [87–93].
Molecular complexes, stable colloidal aggregates of molecules bound by weak interac-
tions, have also been employed as building blocks for the fabrication of PEMs. For example,
Romero et al. [94] have shown that complexes of alginate and the antiTNF-α antibody
can be assembled in LbL films, while the direct assembly of the antibody does not result
in stable layers because of the weak charge of antiTNF-α. PEMs assembled through the
LbL technique can retain a high drug concentration, which affords many possibilities for
the release of therapeutic molecules in a localized manner [95]. Drug reservoirs can be
constructed in PEMs by exploiting the characteristic increase in the amount of polymer,
or polymer therapeutic complexes, deposited as the number of layers increases as associ-
ated with exponentially growing PEMs, not normally observed under linear growth [96].
Drug reservoirs can be achieved by complexing a drug with the polymers assembled
by LbL through electrostatics or hydrogen bonding, or by assembling layers of the drug
between the polymer layers. The exponential or supralinear growth allows for a larger
concentration of drug compared with linear growth and also can be used for designing a
dosage profile as the top layers will entail more drug than the inner layers [97].
Moskowitz et al. [11] proposed a LbL based antibacterial coating with an initial burst
release of gentamicin followed by slow release, which is essential to ensure an initial
inhibition of the adhesion of bacteria during surgery, where there is the highest risk of
infection as the body is open and exposed. A continued and slow release is then required
to avoid bacterial infection during the formation of a protective fibrous capsule and tissue
integration on the implant [98]. The coating was formed by a tetralayer unit containing
gentamicin sulphate, poly acrylic acid (PAA) and a synthetic poly(β-amino ester) (Poly 1),
combined as PAA/Poly 1/PAA/Gentamicin. Gentamicin is a frequently used antibiotic, an
aminoglycan displaying three primary amine groups, which can interact with PAA through
electrostatic interactions and hydrogen bonding. The entire film comprised up to 200
tetralayers (Figure 2A), fabricated over 5 days using an automated procedure. The coatings
comprised of 100 tetralayers (Figure 2C) and had a bactericidal effect against S. aureus
(Figure 2B), resulting in degradation products, which were generally nontoxic towards
MC3T3-E1 pre-osteoblasts [11].
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Figure 2. (A) SEM images of multilayers made of 25 (I), 50 (II), 100 (III) and 200 (IV) tetralayers.
(B) ntibiogram; the titanium rods coated with [Poly 1/poly acrylic acid (PAA)/GS/PAA]200 + [Poly
1/PAA/GS]1 produced a baseline zone of inhibition of 25.6 mm (measured perpendicular to the
long axis of the rod) against S aureus after overnight incubation at 37 ◦C. As a control, the sample is
ref renced to a commercially available BD Sensi-Disc. The lighter color at the rod surface is a result of
the ruptured agar and not the presence of bacteria. The scale bar is in centimeters. (C) 100× images of
MC3T3 cells subjected to 16–18 h treatment in (I) 100 and (II) 200 tetralayer elution buffer. Live cells
are represent d by a blue nucleus urrounded by green cytopl sm. De d cells are represented by a
red nucleus. Reproduced with permission from [11], Elsevier, 2010.
Albright et al. [99] developed a self-defensive multilayer using a chemically crosslinked
LbL hydrogel of poly(methacrylic acid) with a covalently attached pH-sensitive SNARF-1
fluoresc nt layer. The coating contains gentamicin or polymyxin B. Confocal Laser-Scanning
Microscopy images are reported showing that an antibiotic release is triggered by pH changes.
The local acidification generated when bacteria are attached to the surface induced the release
of the antibiotic, yielding a high bacterial killing efficiency for S. aureus and E. coli [99].
De Avila et al. [100] evaluated the antibacterial efficiency of a 10 bilayer film consisting of
poly(acrylic acid) (PAA) and poly-L-lysine (PLL) with tetracycline (TC) incorporated in the
last layer. The multilayer is formed on top of titanium discs, and they obtained an initial burst
release of TC, which has an antibacterial effect against Porphyromonas gingivalis [100]. A. Escobar
et al. [101] prepared an antibacterial coating on titania based on the formation of complexes
of PAA and gentamicin, which are assembled with poly lysine (PLL) (Figure 3A).The multilayer
formation followed an exponential growth (Figure 3B) and was demonstrated to be effective in
preventing the proliferation of S. aureus (Figure 3C) [101]. Only four layers of PAA-gentamicin
complexes and PLL are needed to produce a film with a superior antibacterial performance
as compared to that reported elsewhere [90] The release of gentamicin shows a two-step
profile; an initial burst release followed by a prolonged release lasting more than a month.
Dwivedi et al. [102] used vancomycin to decorate orthopaedic implants with antibacterial
activity against S. aureus, without showing cytotoxic effects on L929 cells (mouse fibroblast
cell line) proliferation. Vancomycin is loaded into niosomes, which are assembled in an
LbL coating formulated as follows: Vancomycin/poly(lactic acid) (PLA)/niosomes, with
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40 tri-layers deposited on top of the orthopaedic implant (bone plates made from stainless
steel) [102]. The same research group recently reported other coatings strategies based on
niosomes containing antibiotics [103,104]. They have coated dental implants alternating
niosomes and PLA comprising two types of niosomes, i.e., the first ones made of sorbitan
stearate (span 60) and the others of cholesterol with encapsulated minocycline [103]. The first
layer is PLA, and then the niosomes are spray coated for 30, 60, 90 and 120 cycles, alternating
both types of niosomes, being each cycle a deposition of span 60 and cholesterol-minocycline
niosomes. Every 30 cycles the implant is dipped into the PLA solution, and then continued
with the electrostatic adsorption of the alternating niosomes. As last step, 50 cycles of poly
(ε-caprolactone) (PCL) nanospheres are spray coated on top of the implant. The authors
observed that when PCL nanospheres are coated on top of the multilayer there is a lower initial
burst release of the antibiotic. The implants in all of the formulations have shown a prolonged
release of minocycline lasting for a week. The amount of minocycline released depends on the
number of cycles of niosome absorption performed to coat the implant, as higher as the cycles,
more antibiotic will be present on the coating. It was also demonstrated that bacterial growth
of P. gingivalis can be inhibited and no toxic side effects have been reported [103].
1 
Figure 3. (A) Scheme of the formation of gentamicin and PAA complexes in 500 Å~10−3 m NaCl at
pH 4.5 (I), LbL assembly of PLL and PAA–gentamicin complexes. The LbL assembly was performed
in 500 Å~10−3 m NaCl at pH 4.5 in four steps: 1. 15 min incubation of 100 µL drop of 1 mg mL−1
PLL, 2. removal of the PLL that has not been adsorbed by dipping the substrate in 500 Å~10−3 m
NaCl pH 4.5, 3. 15 min incubation of 100 µL drop of PAA–gentamicin complexes, and 4. removal
of the complexes that have not been adsorbed by dipping the substrate in 500 Å~10−3 m NaCl pH
4.5. This cycle is repeated four times (II) and scheme of PEMs showing four bilayers of PLL/PAA–
gentamicin complexes grown on top of titania films (III), (B) QCM-D monitoring of Layer-by-Layer
assembly of PLL and PAA–gentamicin complexes and (C) I. S. aureus growth on top of the multilayer
and II. on glass substrates immersed in gentamicin. Cell observer images following 24 h of incubation
of S. aureus on I. top of the multilayer and II. glass immersed in gentamicin, insert images are a zoom
of 4×, and III. CFU of the adhered bacteria on the PEM and glass with gentamicin. Reproduced with
permission from [101], John Wiley and Sons, Inc, 2019.
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Recently, Yavari et al. [105] published a work where multilayers of gelatin (Gel)/bone
morphogenetic protein-2 (BMP-2) and chitosan (CHI)/vancomycin are assembled on the
surface of selectively laser melted porous structures made from commercial titanium.
Their objective was to simultaneously prevent implant-associated infections and stimulate
bone tissue regeneration, as some other published works have previously done, [44,106]
combining the use of bone-specific growth factors and antibiotics to decorate bone titanium
implants [105].
6. LbL for Antimicrobial Peptides Encapsulation
Antimicrobial peptides (AMPs) are short peptides with a broad range of antibacte-
rial activities [107]. They are produced by all life forms. As part of the innate immunity
in higher organisms such as humans they protect them against infections. Moreover,
several AMPs modulate the innate immune response of the host promoting pathogen
clearance. With the global expansion of antibiotic resistance, AMPs are receiving at-
tention as novel therapeutic agents [108,109]. In fact, it has been recently shown that
antibiotic-resistant bacteria show a high frequency of collateral (increased) sensitivity to
AMPs [110]. Antimicrobial peptides have been incorporated into biomaterials using dif-
ferent approaches such as through functionalization of thermoresponsive hydrogels [111],
electrospinning [112], supramolecular interactions [113], and through the Layer-by-Layer
assembly technique [114].
Zhang et al. coated an array of titanium dioxide nanotubes with a multilayer assem-
bled with the antimicrobial peptide ε-polylysine as polication and gum Arabic (polyan-
ion) [115]. The anodized titanium surface was initially functionalized with polydopamine
in order to covalently graft the first layer of ε-polylysine. By means of SEM analysis,
the authors showed that the inner diameter of the nanotubes shrank with the increase in
the number of deposited layers (Figure 4A). The films presented long-term antibacterial
properties up to 3 weeks against both gram-positive S. aureus and gram-negative E. coli
assessed by SEM (Figure 4B,C). Those authors found cracked bacteria (bactericidal activ-
ity) and a decrease in bacteria concentration (antiadhesive effect) on multilayer-coated
nanotubes. Antibacterial activity was enhanced with increasing numbers of assembled
bilayers. The composite film also significantly improved the proliferation and osteogenic
differentiation of rat bone marrow mesenchymal stem cells (rBMSCs) in comparison with
bare polydopamine modified titanium.
Another common strategy in tissue engineering is guided tissue regeneration (GTR),
i.e., a surgical procedure in which a membrane is used to assist affected tissue regeneration
and as a physical barrier to generate space and prevent surrounding undesired tissue
migration (epithelial and connective) into the defective area [117]. In a recent study, He et al.
developed a microsphere-embedded nanofibrous membrane by sequential Layer-by-Layer
electrospinning of gelatin and chitosan, and alternating electrospraying of antimicrobial
peptide (Pac-525)-loaded poly lactic-co-glycolic acid microspheres [116]. The membrane
comprised two blocks, the osteogenic block in which hydroxyapatite nanoparticles were
electrospun along with the gelatin and chitosan, and the barrier block without these
nanoparticles. A scheme of the multilayer structure and composition is depicted in Figure
4D. The membrane exhibited long-term sustained release of Pac-525, bactericidal activity
for one week and bacteriostatic activity for up to a month against both E. coli and S. aureus
(Figure 4E). Moreover, the osteogenic block presented good cell adhesion and proliferation
and promoted osteogenic differentiation of rBMSCs. The adhesion of rBMSCs on the
osteogenic block is shown in Figure 4F.
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and one layer of gum arabic (PL2) and PDA coated with three layers of ε-Polylysine and two
layer of gum arabic (PL3). Morphology of S. aureus (B) and E. coli (C) adhered to each material
examined by SEM. Cracked bacteria appear on the surface (red arrows). An antiadhesive effect
can be seen with the increase in the number of layers (PL2 and PL3) along with the contact-kill
effect. (D) Schematic diagram of the fabrication and structure of the composite membrane by Layer-
by-Layer electrospinning of gelatin (Gln) and chitosan (CS), and alternatively electrospraying of
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In a different approach, Xu et al. employed the Michael addition/Schiff base reaction
to covalently assemble a robust and durable antibacterial multilayer on top of stainless
steel [118]. The authors alternatively assembled tea stain-inspired plant polyphenolic
tannic acid, which later also served as the initiator anchor, and histone-derived parasin I
antifouling-antimicrobial peptide. The resulting coating exhibited good resistance to the
adhesion of Gr m-positive bacteria (S. aureus and S. epidermidis), Gram-negative bacteria
(Pseudomonas sp. and E. coli) and mi roalgae (Amphora coffeaeformis). T ese antifouling
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properties were improved with the increase of the number of bilayers assembled. Shi et al.
reported a multi-layered coating on a titanium surface with prolonged antimicrobial
activity, limited biofilm formation and non-immunotoxicity for dental implant surgery
applications [119]. Polished titanium plates were immersed in chitosan to provide a stable
positive charge. Then, hyaluronic acid and broad-spectrum antimicrobial peptide Tet213
linked to collagen IV were assembled using the Layer-by-Layer technique. The coating
yields long-term release of Tet213 linked collagen, inhibited early S. aureus biofilm forma-
tion and sustained growth inhibition of both Gram-negative anaerobe P. gingivalis and
Gram-positive aerobe S. aureus for up to one month, which is approximately the healing
period for soft tissue after implant placement. In addition, the multilayer presented good
adhesion of HaCaT keratinocyte cell line, non-cytotoxicity, low erythrocyte haemolysis
and had no effect on serum immunoglobulin levels. Since AMPs can be enzymatically
degraded and are expensive to isolate or synthesize, Dorner et al. reported the use of
polymer-based synthetic mimics of antimicrobial peptides (SMAMPs) as actively tune-
able components in LbL multilayers [120]. They synthesized either hydrophobic butyl or
hydrophilic diamine cationic poly(oxanorbornene)-based SMAMPs and assembled them
with anionic poly(acrylic acid). By means of surface plasmon resonance spectroscopy and
Zeta-potential measurements they tuned the LbL assembly conditions in order to increase
film stability and optimize the antimicrobial activity, which was heavily dependent on the
positive charge of the surface.
7. LbL for Antibacterial Nanoparticles Loading
With the increase of antibiotic resistant bacteria strands, antimicrobial metal and metal
oxide nanoparticles are more often proposed as potential therapeutics and alternatives to
antibiotics. Though the antibacterial mechanisms of nanoparticles are not fully understood,
it is currently accepted that microbes are eliminated either by bactericidal effects such as
release of free metal ions, generation of oxidative species, disruption of normal function
of membranes, proteins and DNA, or by bacteriostatic effects coupled with killing by the
host’s immune system [121]. It has been proposed that it is difficult for microbes to become
resistant to nanoparticles, as bacteria would need multiple and simultaneous gene muta-
tions in the same bacterial cell to develop resistance to the multiple mechanisms of action
of nanoparticles [122]. Due to their effective antimicrobial properties and biocompatibility
of Ag ions at low doses, Ag nanoparticles are the most promising and most explored
alternative among antibacterial nanoparticles [123].
Nanoparticles as charged objects can be included in Layer-by-Layer films and de-
posited in between polymeric layers. LbL assembly offers a pathway to increase the
amount of nanoparticles deposited on a surface, as multiple layers of nanoparticles can be
assembled in a sequential fashion.
In reference [124] Carvalho et al. developed multifunctional mussel inspired antibac-
terial bio adhesive films for orthopaedic applications. By means of the Layer-by-Layer
technique the authors combined positively charged polysaccharide chitosan, dopamine-
modified negatively charged polysaccharide hyaluronic acid and silver doped bioactive
glass nanoparticles. SEM images of the multilayer film before and after 7-day immersion on
simulated body fluid solution are shown in Figure 5A. The resulting film supported L929
fibroblast cells adhesion and proliferation (Figure 5B), which were dependent on the partic-
ular order of the assembled layers. Silver ions released from the bioactive glass nanoparti-
cles endowed the coating with antibacterial properties against both E. coli and S. aureus.
These antibacterial properties were evaluated by the inhibition zones in the disk diffusion
methodology (Figure 5C). Moreover, thanks to the hyaluronic acid-dopamine conjugate,
the coating presented good adhesion strength assessed through lap-shear stress tests.
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doped bioactive glass nanoparticles (AgBG) multilayer film before and after immersion on simulated
body fluid solution for 7 days. (B) Live-dead images of L929 fibroblast cells on CHI/HA-DN/AgBG
multilayers 3 and 7 days after seeding. Live cells were labelled with green and the dead cells with red.
(C) Images of the disk diffusion methodology applied to evaluate the antimicrobial properties against
E. coli and S. aureus of CHI/HA-DN multilayers with bioactive glass nanoparticles (BG) and AgBG.
The antimicrobial behaviour of the film with AgBG is demonstrated by the formation of an inhibitory
zone surrounding it. (D) SEM image of a five bilayer-thick film comp sed of P ADMAC and CuNPs.
(E) SEM images of S. aure s on PDADMAC/PSS reference sample and 5-bilay rs CuNPs-containing
coatings. Typical round S. aureus cells forming clusters are observed on the reference sample, whereas
single wrinkled bacteria with disrupted cell membrane are observed on CuNPs-containing coatings.
(A–C) adapted with permission from [124], Royal Society of Chemistry, 2016. (D,E) adapted with
permission from [125], Elsevier, 2019.
Gadkari et al. also reported the use of silver nanoparticle-loaded chitosan as an antibacte-
rial agent in multilayers assembled on fabric [126]. Base layers of anionic poly(styrenesulfonate)
and cationic poly(allyl hy rochloride) were assembled on cationize fabric to provide strong
binding between fibres and main b dy layers of poly(styrenesulfonate) and chitosan or silver
nanoparticles-loaded chitosan. PSS/CHI multilayers pr sented a considerable tibacte ial
effect against both E. coli and S. aureus due to a barrier mechanism/antifouling effect. Multilay-
ers with silver nanoparticle-loaded chitosa were seen to b even more effective due to the
gradual release of s lver ions in addition to t e barrier mechanism. The release of silver ions
increased in going from 5 to 15 bilayers.
In another approach, Liu et al. immobilized bovine serum albumin capped Ag NPs
on a nanoporous polysulfone substrate through Layer-by-Layer interfacial polymeriza-
tion [127]. The thin film was developed by sequential assembly of m-phenylenediamine
aqueous solution, trimesoyl chloride hexane solution and Ag NPs aqueous solution.
Though the Ag NPs presented little effect on the film’s surface contact angle, roughness
and charge, its incorporation has a large effect on antimicrobial activity against E. coli.
Meng et al. employed a 3-dimensional matrix of Layer-by-Layer assembled anionic
poly(acrylic acid) (PAA) and cationic poly(dimethyldiallylammonium) (PDDA) polyelec-
trolytes for in situ growth of silver nanoparticles under UV irradiation [128]. The multilayer
also served to protect the synthesized Ag NPs, prolonging the secretion of Ag ions for as
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long as 120 h. By varying the number of PAA/PDDA bilayers the released amount of silver
ions and thus, the antibacterial efficacy against E. coli and S. aureus could be tuned.
Though silver nanoparticles are the most explored nanoparticle as antimicrobial agents,
other metallic nanoparticles are also being studied. Kruk et al. developed polyelectrolyte-
copper antimicrobial coatings on various surfaces such as silicon, quartz and gold [125].
Those authors sequentially adsorbed positively charged poly(diallyldimethylammonium)
chloride and negatively charged copper nanoparticles. A SEM image of copper nanoparticle
containing multilayer is shown in Figure 5D. The resulting film exhibited antibacterial action
against S. aureus caused by cell lysis upon contact of the bacteria with the surface of the
multilayer (Figure 5E).
8. LbL for Antiadhesive Surfaces
By means of combining chitosan (CHI), a positively-charged biopolymer with an-
timicrobial properties, and hyaluronan (HA), a nontoxic negatively-charged biopolymer
it is possible to generate soft and highly hydrated films [129]. The CHI/HA multilayer
assembly was optimized by changing the pH of the polymer which tunes the ionization
degree of the polyelectrolytes, and by modifying the number of layers. Then, the adhesion
and growth of S. aureus and P. aeruginosa, were studied on the LbL coated surfaces. The best
results in preventing bacterial growth were observed when the surface density of primary
amino groups of top CHI layer was maximized at pH 3 and following the assembly of 18
polyelectrolyte layers. Total suppression of S. aureus’s growth was observed, but little effect
on P. aeruginosa, for which the authors propose the addition of antimicrobial agents. Using
the same combination of polyelectrolytes but different assembly conditions (pH 5 and 15
layers), Muzzio et al. reported a 5-fold decrease in Gram-positive S. aureus and Gram-
negative E. coli adhesion on film-coated surfaces with respect to control uncoated glass
(Figure 6) [130]. Atomic Force Microscopy measurements of CHI/HA films assembled in
these conditions revealed a fibrillar topography with 15–20 nm height and 200–300 nm
width structures (Figure 6A,B). The adhesion was assessed by counting colony forming
units and by GFP-expressing bacteria surface coverage quantification of fluorescent micro-
scope images. The authors correlated the hydrophilicity of the CHI/HA films and their
negative charge to the bacteria resistant characteristics, as both bacteria display a negative
surface charge. The annealed films are slightly more negative and hydrophilic, and display
a significant change in surface topography, with the treated multilayers being smoother
(Figure 6A,B). Moreover, after thermal annealing of the films, a 72-h treatment at 37 ◦C,
the adhesion of S. aureus decreased by a further 20% and no changes in E. coli adhesion
were observed (Figure 6C). The authors correlated this bacteria-specific adhesion resistance
mainly to these topographic differences, as S. aureus are not motile bacteria and possess
no adaptable appendages to overcome the decrease in interaction area, while E. coli can
adapt better to these topography changes as it has a complex machinery of flagella and
fimbriae associated with the cellular wall. The scarce mammalian cell adhesion and protein
absorption was even lower after thermal annealing, achieving a very antifouling coating as
shown in Figure 6D [39,131].
In a recent study, Guo et al. studied changes in physicochemical properties of the
multilayer prepared with the LbL technique such as wettability, surface charge and stiffness
affected the tissue bacteria/surface and cell/surface interactions (Figure 6E,F) [132]. To this
end, they employed branched polyethylenimine (PEI) and custom-synthesized polyanions
with either poly-(ethylene glycol)- or alkyl-carboxylic side-chains. After assembly, they
cross-linked the multilayers to produce stiffer films. S. aureus and E. coli adhesion was
controlled only by the charge and wettability of the surface and was independent of
mechanical properties of the film. A negative charge and hydrophilic surface hindered
both bacteria adhesions (Figure 6E) [132]. On the other hand, while the adhesion of 3T3
fibroblasts was strongly dependent on surface charge and wettability for soft films, a good
cell adhesion was always observed on cross-linked, and thus stiffer films, which was not
dependent on surface charge and wettability (Figure 6F). One can conclude from this work
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that by fine tuning the physicochemical properties of PEMs it is possible to selectively
control/promote or prevent the adhesion of mammalian cells and bacteria.
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ny-forming units (CFU) for S. aureus and E. coli bacteria detached from glass, nonannealed and annealed (CHI/HA)7CHI 
PEMs. (D) C2C12 cell images 24 h post seeding on nonannealed and annealed (CHI/HA)7CHI PEMs. (E) Live staining of 
adherent S. aureus on non-crosslinked LbL films with varying surface isoelectric point (pI) and water contact angle (Θ). 
Scale bar is 100 µm. (F) Fluorescence microscopy images of adherent fibroblast cells stained with DAPI and phalloidin 
after 2 day seeding on non-crosslinked LbL films with varying surface isoelectric point (pI) and water contact angle (Θ). 
Scale bar is 100 µm. (A,B) adapted with permission from [131], American Vacuum Society, 2017. (C,D) adapted with 
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Lu et al. [133] developed a Layer-by-Layer bacteria-responsive hydrogel with pH-
triggered hydrophobicity. They employed as building blocks polyvinylpyrrolidone (PVPON)
and different polyacids with increasing alkyl side chain length: commercial polymethacrylic
acid (PMAA) and poly(2-ethylacrylic acid) (PEAA), poly(2-n-propylacrylic acid) (PPAA)
or poly(2-n-butylacrylic acid) (PBAA). These multilayers showed an increase in elastic
modulus and a decrease in water uptake with increasing polyacid hydrophobicity, i.e., with
increasing length of the alkyl side chain. At physiologic pH 7.4, the more hydrophobic
hydrogels showed a superior resistance to S. epidermidis colonization. As a result of bacteria
proliferation and metabolism, the pH of the medium decreases. As the media acidifies the
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more hydrophobic hydrogels tend to dehydrate and kill bacteria upon contact by exposing
polyvinylpyrrolidone cationic groups, which protonate at acidic pHs, and are capable of
disrupting bacteria membranes. Both the antiadhesive and killing efficiency were enhanced
by the polymer hydrophobicity. These hydrogels do not display free cationic groups under
physiological conditions, and displayed good adhesion and cytocompatibility for human
osteoblasts.
Polyelectrolyte multilayers can also be prepared by host–guest interaction. Taking
into account the results reported on the antifouling properties of PEI and the antimicro-
bial properties of chitosan (CHI) [134], the authors assembled a multilayer of synthetic
polyethylenimine-β-cyclodextrin (PEI-β-CD) and synthetic ferrocene-modified chitosan
(Fc-CHT). The cyclodextrin and ferrocene modifications allow for the build-up of the film
applying the Layer-by-Layer principle of sequential assembly through coordination chem-
istry of two polymers of the same charge. The antifouling and antimicrobial performance
against Pseudomonas sp. and S. aureus increased with the number of host-guest bilayers.
9. Multifunctional Antimicrobial Multilayers
Each antibacterial strategy, such as loading of nanoparticles, antimicrobial peptides
and antibiotics or the engineering of the multilayer to endow it with contact-killing or
antiadhesive properties, has its advantages and limitations. The versatility of the LbL
assembly technique lies in the possibility of the synergistic integration of different strategies
in order to generate multifunctional coatings.
In this vein, Tang et al. loaded polyelectrolyte multilayers (PEMs) composed of
poly(allylamine hydrochloride) (PAH) and poly(acrylic acid) (PAA) with silver nanoparti-
cles (Ag NPs) [135]. The hydrated, swollen nature of the PAH/PAA multilayers resulted in
an anti-adhesive coating, and the immobilization of the Ag NPs within the film enhanced
the contact probability of NPs and bacteria, increasing the killing efficiency.
Enzymes that generate antimicrobial agents such as hydrogen peroxide can be incor-
porated in multilayers films to confer it with bactericidal properties. In reference [136]
the authors immobilized the antibacterial hydrogen peroxide (H2O2) producing enzyme
cellobiose dehydrogenase (CDH) in a multilayer with novel antifouling and contact killing
polymeric building blocks. They synthetized an antifouling copolymer with zwitterionic
and quaternary ammonium side groups and a contact killing derivative of that poly-
mer with octyl groups. The resulting polycations were alternatively assembled with
poly(styrenesulfonate) as the polyanion. The enzyme CDH was embedded as a polyanionic
layer in the multilayer system due to its negative charge. The location of the enzyme
in the multilayer was found to influence its activity. The resulting films presented both
antifouling and antimicrobial properties [136].
Kurapati et al. [137] synergistically combined two kinds of antimicrobial therapies
using the Layer-by-Layer assembly technique. The authors assembled 20 to 80 layers of
positively charged poly(allylamine hydrochloride) and negatively charged graphene oxide,
which has intrinsic antimicrobial properties by damaging the bacteria cell wall with its
sharps edges (nanoknives). The increase in the number of layers leads to an increase in
antibacterial activity against E. coli due to the increase in film roughness and graphene
oxide content. By exposing the films to a near-infrared lasers the authors exploited the
photothermal properties of graphene oxide and enhanced the coating antibacterial ef-
ficiency. The results suggest that the combined antimicrobial effects (membrane stress
+ photothermal heating) cause increased bacteria lysis in comparison to the individual
effects [137]. A brief summary of the LbL assemblies for antibiotic encapsulation and with
other antibacterial mechanisms are presented in Table 1.
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Table 1. Summary of antibacterial Layer-by-Layer strategies reviewed in this article.
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upon contact of the bacteria with the
surface of the multilayer
[125]
Pharmaceutics 2021, 13, 16 16 of 23
Table 1. Cont.
Antibacterial
Mechanism Composition Bacteria Tested Findings Reference
Antiadhesive Surface CHI, HA S. aureus (Gram+) andP. aeruginosa (Gram−)
Antibacterial properties can be tuned by
changing the pH of the polymer
solutions and number of layers.
Total suppression of S. aureus’s growth,
little effect on P. aeruginosa.
[129]
Antiadhesive Surface CHI, HA S. aureus (Gram+) andE. coli (Gram−)
Low bacteria adhesion on films. After







S. aureus (Gram+) and
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Surface charge and wettability control




























PAH, PAA, silver NPs E. coli (Gram−)
Antiadhesive properties due to
PAH/PAA and bactericidal properties










The location of the hydrogen
peroxide-producing enzyme in the
multilayer was found to influence its
activity. The films presented both






graphene oxide E. coli (Gram−)
Combined antimicrobial effects
(membrane stress + photothermal
heating) cause increased bacteria lysis in
comparison to the individual effects
[137]
Abbreviations: poly acrylic acid (PAA), poly(β-amino ester) (Poly 1), Gram positive (Gram+), Gram negative (Gram−), poly-L-lysine
(PLL), poly(lactic acid) (PLA), bone morphogenetic protein-2 (BMP-2), chitosan (CHI), poly lactic-co-glycolic acid (PLGA), rat bone marrow
mesenchymal stem cells (rBMSCs), hyaluronic acid (HA), nanoparticles (NPs), poly(styrenesulfonate) (PSS), poly(allyl hydrochloride)
(PAH), Bovine serum albumin (BSA), poly(dimethyldiallylammonium) (PDDA), polyethylenimine (PEI), polyvinylpyrrolidone (PVPON).
10. Layer-by-Layer Assembly among Other Localized Antibacterial Strategies
The use of Layer-by-Layer coating is one approach among the many explored for the
development of antimicrobial coatings that can be found in literature [6,41,138]. Polymer
grafting is an attractive approach, which offers similar advantages to LbL regarding encap-
sulation of antibiotics, functionalization with peptides, and used in combination with other
antibacterial materials [139]. For example, ionic polymers such as poly(sodium styrene
sulfonate (polyNaSS) have been grafted to a titanium surface, reducing the adhesion of
S. aureus, and which can be further used to immobilize antimicrobial molecules [139,140].
Covalent bonding offers a strong link between the coating and the material, resulting in a
durable interface [141], but the chemical reactions needed to covalently bind the polymers
often result in sparse films. Additionally there are difficulties to covalently attach a polymer
over a relatively large surface in an implant [142]. LbL on the other hand is easy to apply
over large areas by either dipping or spraying.
Surface nanostructuring has also gained attention as a means to reduce bacteria pro-
liferation. Ercan et al. [143] showed that surface modification by depositing Ti nanotubes
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changes the bacterial response. Other works have also demonstrated the effectivity against
S. aureus, S. epidermidis and P. aeruginosa [143,144], This approach is based on the develop-
ment of anti-adhesion surfaces; thus, they are not only effective in preventing bacterial
adhesion but they also inhibit the adhesion of osteoblasts. Due to the weak adhesion of
osteoblasts, the integration of the implant into the surrounding tissue cannot occur [145].
As we have also seen, LBL can be used to decrease bacteria adherence to surfaces in
conditions where osteoblast adherence is also hindered.
Another potential strategy for a localized antibacterial action is based on incorporating
ions with a bactericidal action on the surface of the implant. Ion-implanted surfaces with
elements such as fluorine (F), zinc (Zn) calcium (Ca), chlorine (Cl), iodine (I), copper (Cu),
cerium (Ce) or selenium (Se), all displaying an antibacterial action can be incorporated
to the coating through anodic oxidation of the ions. By the Magnetron Sputtering (MS)
technique, a plasma is made to interact with a solid target in a vacuum reactor, producing
the sputtering of atomic species from a well-defined race-track region, and their deposition
on a substrate located a few centimetres away [146]. Several works have used this technique
to implant ions in the Ti coating [25,147–149]. The hydroxylation of this ions once they
are in contact with bacteria leads to the formation of reactive components (HCl, HOCl or
H2O2, to name but a few), which cause oxidation of the cell membranes, leading to an
increased permeability of cells, and finally to cell death [150]. Consequently, these reactive
compounds are also going to interfere with osteoblast proliferation, avoiding implant
proper integration.
11. Concluding Remarks and Future Perspectives
The lLayer-by-Layer technique offers multiple possibilities for the design of antibacte-
rial coatings that can be assembled on implants. Some of the approaches revised in this
manuscript have been directed towards antibacterial coatings in different scenarios from
a bone implant, but could also be adapted for coating an implant. The simple, straight-
forward and inexpensive methodology behind LbL: a sequential assembly of oppositely
charged polyelectrolytes from aqueous solutions, and the possibility of spraying poly-
electrolyte for coating larger surfaces makes LbL highly appealing for implant coating
in comparison with other potential polymeric coating methods, like polymer brushes or
hydrogels when we think of covering large surfaces. LbL assemblies can be used to load
antibiotics on the implant surface for a localized and prolonged release at the site of the
implant. LbL can also be used to decorate the implant with antibacterial peptides and
nanoparticles, and by choosing the proper polymers and assembly conditions LbL films
can prevent bacteria adhesion on the surface. Moreover, LbL can combine all strategies
in a single film, enhancing the bactericidal potential of the coating and allowing for the
design of strategies for fighting biofilm formation and bacterial infections, while at the
same time the formation of tissue on an implant is not harmed. This is indeed the main
goal of LbL research for antibacterial coatings should target now. PEMs must be designed
as antibacterial and osteogenic. Issues such as the dosage of encapsulated antibiotics must
be also addressed. An optimal coating with encapsulated antibiotics will demand a larger
release during surgery and immediately after since the risk of infection is high. At the
same time a continuous antibacterial action but with a smaller dose of antibiotics being
released for weeks is necessary to avoid the occurrence of bacterial focus. LbL films could
be used for encapsulating more than one antibiotic to be delivered in a synergistic or
sequential manner. Another challenge for LbL films is the design of coatings that in the
case of formation of a biofilm could be capable of fighting it.
Safety issues also represent a challenge for LbL coatings. While having an antibacterial
action, the coating should not pose a risk to humans. It should also not lead to cell death or
inflammatory responses, and should not hinder cells from adhering to the implant. Many
of the examples provided in this review involve components, polymers or nanomaterials, of
synthetic origin, that are not necessarily biodegradable, which may represent some risk for
the host. Most likely, LbL films based on biodegradable polyelectrolyte have more potential
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for translation. However, “the dose makes the poison”, and the amount of polymer per
layer of polyelectrolyte is in the range of a few to tens of ng per cm2 [151], which may
translate in exposing the patients to very small doses of nanomaterials or polymers. Despite
the number of publications on the topic of LbL for antibacterial applications few works
have reached in vivo experimentation, which is a necessary step for future applications
and for a proper safety evaluation of the coatings.
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